Blanke CD

No ORCID on file · 1 paper in corpus · active 2026
2026
Journal for immunotherapy of cancer ·doi:10.1136/jitc-2025-012805

BackgroundDual anti-CTLA-4/PD-1 inhibitors show efficacy in numerous malignancies. We are the first to report on the efficacy of ipilimumab-nivolumab immunotherapy in a dedicated cohort of patients with gynecologic clear cell carcinomas (CC…